Literature DB >> 12324559

Antithrombotic therapy after myocardial infarction.

Richard C Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12324559     DOI： 10.1056/NEJMe020097

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Warfarin in vulnerable older adults with atrial fibrillation.

Authors:  S Michael Gharacholou; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2009-05       Impact factor: 2.300

Review 2.  Antithrombotic therapy in acute coronary syndromes: guidelines translated for the clinician.

Authors:  S Michael Gharacholou; Renato D Lopes; Jeffrey B Washam; L Kristin Newby; Stefan K James; John H Alexander
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

3.  Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, Brazil.

Authors:  Renato D Lopes; David Garcia; Richard C Becker; Christopher B Granger; L Kristin Newby; John H Alexander; E Marc Jolicoeur; Allison Handler; Karen S Pieper; Antonio C Carvalho; Helio P Guimaraes; Dalton A F Chamone; Antonio C Baruzzi; Fabio S Machado; Ari Timerman; Antonio C Lopes
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

4.  Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice.

Authors:  H Lee; S A Sturgeon; J K Mountford; S P Jackson; J R Hamilton
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.

Authors:  Renato D Lopes; Richard C Becker; John H Alexander; Paul W Armstrong; Robert M Califf; Mark Y Chan; Mark Crowther; Christopher B Granger; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Kenneth W Mahaffey; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; Antonio C Carvalho; Roberto R Giraldez; Helio P Guimaraes; Helena B Nader; Renato A K Kalil; Joyce M A Bizzachi; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

6.  P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.

Authors:  Jose A Diaz; Shirley K Wrobleski; Christine M Alvarado; Angela E Hawley; Nichole K Doornbos; Patrick A Lester; Suzan E Lowe; Joy E Gabriel; Karen J Roelofs; Peter K Henke; Robert G Schaub; Thomas W Wakefield; Daniel D Myers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-05       Impact factor: 8.311
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.